Late Presentation of Xeroderma Pigmentosa With Squamous Cell Carcinoma in Septic Shock: Report of a Rare Case.

dermato-oncology pediatric rare diseases pediatrics emergency rare skin disease septic shock in children squamous cell neoplasm xeroderma pigmentosum

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Jun 2022
Historique:
accepted: 15 06 2022
entrez: 20 7 2022
pubmed: 21 7 2022
medline: 21 7 2022
Statut: epublish

Résumé

Xeroderma pigmentosum (XP) is a rare autosomal recessive pathology affecting nucleotide excision repair against ultraviolet radiation. This leads to an increased predisposition to developing ophthalmological, neurological, and cutaneous conditions with an increased cell turnover. This case reports a late presentation of XP presenting with metastatic squamous cell carcinoma (SCC) and septic shock in an eight-year-old Indian male. Emergency management with IV fluid boluses and broad-spectrum antibiotics showed no improvement in vitals. Urgent surgical debridement and tumor debulking failed to improve laboratory values. Postoperative leukocytosis with fever spikes warranted the need to transfer the patient to a super-specialty oncology unit. Such an adverse presentation is commonly seen in XP-related invasive squamous cell carcinoma. Preventive management requires early identification and a multidisciplinary approach involving dermatologists, ophthalmologists, and surgeons. Late presentations revolve around control of the disease process by sharp debridement and chemotherapy with regular surveillance as the lesions tend to reoccur even after excision and chemotherapy.

Identifiants

pubmed: 35855222
doi: 10.7759/cureus.25967
pmc: PMC9286006
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e25967

Informations de copyright

Copyright © 2022, Pinto et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Dtsch Dermatol Ges. 2003 Mar;1(3):191-8
pubmed: 16285494
J Invest Dermatol. 2012 Mar;132(3 Pt 2):785-96
pubmed: 22217736
Arch Dermatol. 1987 Feb;123(2):241-50
pubmed: 3545087
Indian J Surg Oncol. 2014 Jun;5(2):120-4
pubmed: 25114464
Brain. 2008 Aug;131(Pt 8):1979-89
pubmed: 18567921
Photochem Photobiol. 2019 Jan;95(1):140-153
pubmed: 30565713
Orphanet J Rare Dis. 2011 Nov 01;6:70
pubmed: 22044607
PLoS One. 2013 Nov 13;8(11):e78678
pubmed: 24236034
J Clin Exp Dent. 2012 Oct 01;4(4):e248-51
pubmed: 24558564
Br J Pharmacol. 2019 Nov;176(22):4293-4301
pubmed: 30499105
Brain. 2008 Aug;131(Pt 8):1967-8
pubmed: 18669491
Ophthalmology. 2013 Jul;120(7):1324-36
pubmed: 23601806
Photochem Photobiol. 2015 Mar-Apr;91(2):475-83
pubmed: 25382223
ScientificWorldJournal. 2013 Dec 29;2013:534752
pubmed: 24459435

Auteurs

Christopher J Pinto (CJ)

Medical Research, Karnataka Insititute of Medical Sciences, Hubballi, IND.

Rajesh Nayyar (R)

Internal Medicine, Washington University School of Medicine, Washington, USA.

Dandamudi Asvita (D)

Emergency Medicine, MediCiti Institute of Medical Sciences, Ghanpur, IND.

Avinash Chirumamilla (A)

Infectious Diseases, Kanachur Institute of Medical Sciences, Natekal, IND.

Prachi Patel (P)

Medicine, Tianjin Medical University, Tianjin, CHN.

Classifications MeSH